<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> carries a 30- to 100-fold increased risk of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, which is thought to develop via a <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> progression </plain></SENT>
<SENT sid="1" pm="."><plain>A common genetic abnormality detected in Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is loss of heterozygosity (LOH) at the sites of known or putative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes, of which there are at least 9 associated with esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to identify at which histological stage of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> LOH at these sites occur </plain></SENT>
<SENT sid="3" pm="."><plain>Microdissection of multiple paraffin-embedded tissue blocks from 17 esophagogastrectomy specimens of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> arising in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> yielded areas of <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, low-, intermediate- and high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>LOH analysis of microdissected tissues was performed using a double polymerase chain reaction technique with 11 microsatellite primers shown previously to have LOH in at least 30% of esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Identical LOH was detected in premalignant and malignant tissues in 4 of 17 patients, and was located at 5q21-q22 (D5S346 primer), 17p11.1-p12 (TCF2 primer), 17p13.1 (TP53 primer), 18q21.1 (detected in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene [<z:chebi fb="8" ids="53090">DCC</z:chebi>] primer), and 18q23-qter (D18S70 primer) </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that LOH at the sites of the <z:chebi fb="8" ids="53090">DCC</z:chebi>, <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC), and TP53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes occur before the development of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and so merit further study as potential biomarkers of <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> undergoing endoscopic and histological surveillance </plain></SENT>
</text></document>